Pfizer names head of oncology as new R&D chief

Pfizer (NYSE:PFE) on Wednesday promoted Chris Boshoff, the executive in charge of its oncology business, as the company’s new chief scientific officer, a role responsible for overseeing the drugmaker’s R&D efforts.

Boshoff, who has headed the New York-based pharma giant’s cancer